1 receptor inhibitors of insulin growth factor type to inhibit tumor cell growth.

A cytotoxic agent or chemotherapeutic agent and a composition comprising an inhibitor of factor receptor insulin-like 1 (IGF-1R) for use in inhibiting the growth of multiple myeloma cells in a subject growth, wherein said IGF-1R inhibitor is ADW-742 or NVP-AEW541.